Long term follow-up study to evaluate immunogenicity and safety of a single dose of live attenuated hepatitis a vaccine in children

References

• Zhuang FC, Qian W, Mao ZA, Gong YP, Jiang Q, Jiang LM, Chen NL, Chai SA, Mao JS. Persistent efficacy of live attenuated hepatitis A vaccine (H2-strain) after a mass vaccination program. Chin Med J (Engl) 2005; 118:1851-6; PMID:16313838
   PubMed Web of Science ®Google Scholar
• Wang X-Y, Xu Z, Yao X, Tian M, Zhou L, He L, Wen Y. Immune responses of anti-HAV in children vaccinated with live attenuated and inactivated hepatitis A vaccines. Vaccine 2004: 1941-5; PMID:15121306; http://dx.doi.org/10.1016/j.vaccine.2003.11.007
   PubMedGoogle Scholar
• Zhang Y, Liu X, Ma J. A field evaluation of the epidemiological efficacy of an attenuated live hepatitis A vaccine (H2 strain). Zhonghua Yu Fang Yi Xue Za Zhi 2001; 35:387-9; PMID:11840766
   PubMedGoogle Scholar
• WHO position paper on hepatitis A vaccines: June 2012. Wkly Epidemiol Rec 2012; 87:261-76; Available from: http://www.who.int/wer/2012/wer8728_29.pdf?ua=1
   PubMedGoogle Scholar
• Center for Disease Control and Prevention. Prevention of hepatitis A through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1999; 48:1-37; PMID:10543657
   PubMedGoogle Scholar
• World Health Organization [Internet]. Global vaccine safety, Live attenuated hepatitis A vaccine [cited 22 May, 2014]; Available from: http://www.who.int/vaccine_safety/committee/topics/hepatitisa/Jun_2010/en/
   Google Scholar
• Baxter D. Active and passive immunity, vaccine types, excipients and licensing. Occup Med (Lond) 2007; 57:552-6; PMID:18045976; http://dx.doi.org/10.1093/occmed/kqm110
   PubMed Web of Science ®Google Scholar
• Mao JS. Development of live, attenuated hepatitis A vaccine (H2-strain). Vaccine 1990; 8:523-4; PMID:1965075; http://dx.doi.org/10.1016/0264-410X(90)90001-3
   PubMed Web of Science ®Google Scholar
• WHO position paper on hepatitis A vaccines: June 2012-Recommendations Meeting Report. Vaccine 2013; 31:285-6; PMID:23142134; http://dx.doi.org/10.1016/j.vaccine.2012.10.102
   PubMed Web of Science ®Google Scholar
• Bhave S, Bavdekar A, Sapru A, Bawangade S, Pandit A. Immunogenicity of single dose live attenuated hepatitis a vaccine. Indian Pediatr 2011; 48:135-7; PMID:21169655; http://dx.doi.org/10.1007/s13312-011-0039-4
   PubMed Web of Science ®Google Scholar
• Dhawan PS, Shah SS, Alvares JF, Kher A, Shankaran, Kandoth PW, Sheth PN, Kamath H, Kamath A, Koppikar GV, Kalro RH. Seroprevalence of hepatitis A virus in Mumbai, and immunogenicity and safety of hepatitis A vaccine. Indian J Gastroenterol 1998; 17:16-8; PMID:9465507
   PubMedGoogle Scholar
• Franco E, Meleleo C, Serino L, Sorbara D, Zaratti L. Hepatitis A: epidemiology and prevention in developing countries. World J Hepatol 2012; 4:68-73; PMID:22489258; http://dx.doi.org/10.4254/wjh.v4.i3.68
   PubMedGoogle Scholar
• Nagasawa SY, Okamura T, Iso H, Tamakoshi A, Yamada M, Watanabe M, Murakami Y, Miura K, Ueshima H. Relation between serum total cholesterol level and cardiovascular disease stratified by sex and age group: a pooled analysis of 65 594 individuals from 10 cohort studies in Japan. J Am Heart Assoc 2012; 1:e001974; PMID:23316288; http://dx.doi.org/10.1161/JAHA.112.001974
   PubMed Web of Science ®Google Scholar
• Mao JS, Chai SA, Xie RY, Chen NL, Jiang Q, Zhu XZ, Zhang SY, Huang HY, Mao HW, Bao XN, et al. Further evaluation of the safety and protective efficacy of live attenuated hepatitis A vaccine (H2-strain) in humans. Vaccine 1997; 15:944-7; PMID:9261939; http://dx.doi.org/10.1016/S0264-410X(96)00304-0
   PubMed Web of Science ®Google Scholar
• Sharapov UM, Bulkow LR, Negus SE, Spradling PR, Homan C, Drobeniuc J, Bruce M, Kamili S, Hu DJ, McMahon BJ. Persistence of hepatitis A vaccine induced seropositivity in infants and young children by maternal antibody status: 10-year follow-up. Hepatology 2012; 56:516-22; PMID:22371069; http://dx.doi.org/10.1002/hep.25687
   PubMed Web of Science ®Google Scholar
• Zhao YL, Meng ZD, Xu ZY, Guo JJ, Chai SA, Duo CG, Wang XY, Yao JF, Liu HB, Qi SX, et al. H2 strain attenuated live hepatitis A vaccines:protective efficacy in a hepatitis A outbreak. World J Gastroenterol 2000; 6:829-32; PMID:11819704
   PubMed Web of Science ®Google Scholar
• Wang XY, Xu ZY, Ma JC, von Seidlein L, Zhang Y, Hao ZY, Han OP, Zhang YL, Tian MY, Ouyang PY, et al. Long-term immunogenicity after single and booster dose of a live attenuated hepatitis A vaccine: results from 8-year follow-up. Vaccine 2007; 25:446-9; PMID:16949710; http://dx.doi.org/10.1016/j.vaccine.2006.08.004
   PubMed Web of Science ®Google Scholar
• Vacchino MN. Incidence of Hepatitis A in Argentina after vaccination. J Viral Hepat 2008; 15 Suppl 2:47-50; http://dx.doi.org/10.1111/j.1365-2893.2008.01029.x
   PubMed Web of Science ®Google Scholar
• Mayorga Perez O, Herzog C, Zellmeyer M, Loaisiga A, Frosner G, Egger M. Efficacy of virosome hepatitis A vaccine in young children in Nicaragua: randomized placebo-controlled trial. J Infect Dis 2003; 188:671-7; PMID:12934183; http://dx.doi.org/10.1086/377309
   PubMed Web of Science ®Google Scholar
• Ott JJ, Wiersma ST. Single-dose administration of inactivated hepatitis A vaccination in the context of hepatitis A vaccine recommendations. Int J Infect Dis 2013; 17:e939-44; PMID:23791857; http://dx.doi.org/10.1016/j.ijid.2013.04.012
   PubMedGoogle Scholar
• Mao JS, Xie RY, Huang HY, Chai SA, Chen NL, Yu PH, Wan XZ, Liu CJ, Cao YY, Dong DX, et al. Studies in monkeys of attenuated hepatitis A variants. Sci Sin B 1988; 31:338-43; PMID:2842861
   PubMedGoogle Scholar
• Berger R, Just M, Althaus B. Time course of hepatitis A antibody production after active, passive and active/passive immunisation: the results are highly dependent on the antibody test system used. J Virol Methods 1993; 43:287-97; PMID:8408443; http://dx.doi.org/10.1016/0166-0934(93)90147-J
   PubMed Web of Science ®Google Scholar
• National Institutes of Health [Internet]. National Institute of Allergy and Infectious Diseases. Vaccines. [Updated 2013 April; cited 2014 May 22] Available from: http://www.niaid.nih.gov/topics/ vaccines/understanding/pages/typesvaccines.aspx
   Google Scholar
• Xie H, Cass AR, Barrett AD. Yellow fever 17D vaccine virus isolated from healthy vaccinees accumulates very few mutations. Virus Res 1998; 55:93-9; PMID:9712515; http://dx.doi.org/10.1016/S0168-1702(98)00036-7
   PubMed Web of Science ®Google Scholar
• Bhave S, Bavdekar A, Madan Z, Jha R, Bhure S, Chaudhari J, Pandit A. Evaluation of immunogenicity and tolerability of a live attenuated hepatitis a vaccine in Indian children. Indian Pediatr 2006; 43:983-7; PMID:17151402
   PubMed Web of Science ®Google Scholar
• Faridi MM, Shah N, Ghosh TK, Sankaranarayanan VS, Arankalle V, Aggarwal A, Sathiyasekaran M, Bhattacharya N, Vasanthi T, Chatterjee S, et al. Immunogenicity and safety of live attenuated hepatitis A vaccine: a multicentric study. Indian Pediatr 2009; 46:29-34; PMID:19179715
   PubMed Web of Science ®Google Scholar
• SAGE. [Internet]. SAGE hepatitis A working group report 2012. [Cited 2014 May 22]. Available from: http://www.who.int/immunization/sage/meetings/2012/april/1_HepAYellowBook_23Ma-rch.pdf
   Google Scholar